Chronic Obstructive Pulmonary Disease. Chronic obstructive pulmonary disease, unspecified
Conditions
Interventions
Intervention 1: Control group: Patients in the control group receive conventional therapy (triple therapy) and placebo. Triple therapy includes inhaled anticholinergics (long-acting, short-acting), in
Sponsors
Shahre-kord University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 70 Years
Inclusion criteria
Inclusion criteria: Diagnosis of COPD by an internal medicine physician, based on the classification of global pioneers of chronic obstructive pulmonary disease (GOLD) No other chronic diseases such as orthopedic and motor diseases, multiple sclerosis or cancer. hospitalization stability of the patient's physical and mental condition
Exclusion criteria
Exclusion criteria: Lack of motivation of the patient to cooperation Immune system defects (recurrent respiratory infections and worsening of shortness of breath) Existence of concomitant asthma Complications of azithromycin non-pulmonary diseases like cancer; liver dysfunction, cholestatic jaundice, Infiltration and consolidation in chest x-ray Patients with acute exacerbation of COPD Existence of atopy or allergic rhinitis pneumonia embolism Kidney failure hearing loss
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FEV1/ FVC. Timepoint: Two months after starting the study. Method of measurement: Spirometry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactEbrahim Abbasi Monjezi
Shahre-kord University of Medical Sciences
Outcome results
None listed